Automated Telephone Monitoring for Symptom Management
ATSM
1 other identifier
interventional
526
1 country
1
Brief Summary
To improve the management of symptoms, patients with cancer undergoing chemotherapy will be monitored using an automated telephone system to record the severity of 15 prevalent symptoms for up to 8 consecutive weeks. Outcomes include; significant reduction in symptom severity and improvement in health states.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Apr 2003
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2006
CompletedFirst Submitted
Initial submission to the registry
November 25, 2008
CompletedFirst Posted
Study publicly available on registry
November 27, 2008
CompletedDecember 7, 2011
December 1, 2011
3.6 years
November 25, 2008
December 6, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lower reported mean severity index among 7 prevalent symptoms
9 weeks, 15 weeks
Secondary Outcomes (1)
Reduced impact of physical role performance, improved social functioning, and reduced emotional distress; improved levels of communication between patients and providers; and improved patient satisfaction with care.
9 weeks, 15 weeks
Study Arms (2)
Nurse
EXPERIMENTALReceives symptom management assistance from an oncology nurse via the telephone
AVR
EXPERIMENTALReceives symptom management assistance from an Automated telephone system
Interventions
Eligibility Criteria
You may qualify if:
- years of age or older
- solid tumor cancer diagnosis
- receiving chemotherapy treatment
You may not qualify if:
- Emotional or psychology disorder for which patient is receiving treatment
- does not speak English
- does not have access to a telephone
- difficulty hearing on the telephone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Michigan State University
East Lansing, Michigan, 48824, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles Given, PhD
Michigan State University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 25, 2008
First Posted
November 27, 2008
Study Start
April 1, 2003
Primary Completion
November 1, 2006
Study Completion
November 1, 2006
Last Updated
December 7, 2011
Record last verified: 2011-12